Related Experiment Video
Updated: Mar 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
[Mediastinal lymphomas]
S Rauthe1,2, A Rosenwald3,4
1Institut für Pathologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Deutschland.
Insights
Mediastinal lymphomas, including classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma, present diagnostic challenges. Accurate identification is crucial for appropriate treatment and prognosis, especially for mediastinal grey zone lymphomas.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Mediastinal lymphomas pose diagnostic and clinical challenges, often presenting as emergencies with small biopsy samples.
- Classical Hodgkin's lymphoma (CHL), predominantly the nodular sclerosis subtype, is the most common mediastinal lymphoma.
- Distinguishing CHL from primary mediastinal large B-cell lymphoma (PMBCL) is critical due to different treatment strategies.
Purpose of the Study:
- To highlight the diagnostic difficulties in mediastinal lymphomas, particularly differentiating CHL from PMBCL.
- To emphasize the importance of recognizing mediastinal grey zone lymphomas (MGZL) with intermediate features.
- To discuss rare mediastinal lymphomas like extranodal thymic marginal zone lymphomas (MALT type) and T-lymphoblastic lymphomas.
Main Methods:
- Morphological assessment of small biopsy samples.
- Immunohistochemical analysis to identify cell phenotypes (e.g., CD20, CD79a, CD30).
- Differential diagnosis including thymomas and thymic hyperplasia for T-lymphoblastic lymphomas.
Main Results:
- Morphological and immunohistochemical detection of Hodgkin and Reed-Sternberg cells can be challenging in sclerotic CHL.
- PMBCL exhibits sheets of blast cells with a strong B-cell phenotype (CD20+, CD79a+), often CD30+.
- MGZL shows intermediate features between CHL and PMBCL, associated with a slightly poorer prognosis.
Conclusions:
- Accurate diagnosis of mediastinal lymphomas, including CHL, PMBCL, and MGZL, is essential for guiding therapy.
- Immunohistochemistry is vital for characterizing cell phenotypes and distinguishing between these lymphoma subtypes.
- Rare mediastinal lymphomas and T-lymphoblastic lymphomas require careful differential diagnosis to ensure appropriate management.
Abstract:
Lymphomas infiltrating the mediastinum are a challenge for the treating physician as well as for the pathological diagnostics. The clinical scenario is often an emergency situation, while the pathologist is usually confronted only with small biopsy samples. Classical Hodgkin's lymphoma is by far the most frequently occurring lymphoma in the mediastinum and predominantly the nodular sclerosis subtype. In small and very sclerotic specimens it can be difficult to morphologically detect Hodgkin and Reed-Sternberg cells and to identify the characteristic phenotype by immunohistochemistry. Primary mediastinal large B‑cell lymphomas should be distinguished from classical Hodgkin's lymphomas as the treatment is different. This is characterized by the detection of sheets of blast cells, which immunohistochemically show a strong B‑cell phenotype (positivity for CD20 and CD79a), while CD30 can also often be expressed. The intimate biological relationship between classical Hodgkin's lymphomas and mediastinal large B‑cell lymphomas is illustrated by the existence of B‑cell lymphomas with intermediate features (so-called mediastinal grey zone lymphomas). It is important to recognize and diagnose these lymphomas as they are associated with a slightly inferior prognosis. Extranodal thymic marginal zone lymphomas of the mucosa-associated lymphoid tissue (MALT) type are a rare form of lymphoma encountered in the mediastinum, which can be associated with autoimmune diseases. T‑lymphoblastic lymphomas and leukemia, which occur predominantly in children and young adults, represent a rapidly growing precursor cell neoplasia and must be distinguished from thymomas in the differential diagnostics as well as from normal and hyperplastic thymus glands.
More Related Videos
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017